Tech Company Financing Transactions

Obalon Therapeutics Funding Round

On 1/14/2015, Obalon Therapeutics landed $30 million in Series D funding from Axon Ventures, Domain Associates and InterWest Partners.

Transaction Overview

Company Name
Obalon Therapeutics
Announced On
1/14/2015
Transaction Type
Debt
Debt
Venture Equity
Venture Equity
Amount
$30,000,000
Round
Series D
Investors

Axon Ventures

Domain Associates (Kim Kamdar)

InterWest Partners (Douglas Fisher)

Mirae Asset Venture Investment

Okapi Venture Partners (Sharon Stevenson)

Proceeds Purpose
Proceeds of the new financing will be used primarily to fund U.S. clinical trials to support the U.S. Food and Drug Administration (FDA) approval of the Obalon balloon, a novel, nonsurgical, fully-reversible device for weight loss.

Company Information

Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
5421 Avenida Encinas F
Carlsbad, CA 92008
USA
Phone
(760) 607-5151
Website
www.obalon.com
Email Address
Not Recorded
Overview
The Obalon (NASDAQ: OBLN) balloon assists with weight loss by helping you feel full sooner and eat less. This, along with diet and exercise, jump-starts your efforts, proving that when it comes to losing weight, less is truly more.
Profile
Obalon Therapeutics LinkedIn Company Profile
Social Media
Obalon Therapeutics Company Twitter Account
Company News
Obalon Therapeutics News
Facebook
Obalon Therapeutics on Facebook
YouTube
Obalon Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Andrew Rasdal
  Andrew Rasdal LinkedIn Profile  Andrew Rasdal Twitter Account  Andrew Rasdal News  Andrew Rasdal on Facebook
Chief Executive Officer
William Plovanic
  William Plovanic LinkedIn Profile  William Plovanic Twitter Account  William Plovanic News  William Plovanic on Facebook
Chief Technical Officer
Mark Brister
  Mark Brister LinkedIn Profile  Mark Brister Twitter Account  Mark Brister News  Mark Brister on Facebook
VP - Finance
Nooshin Hussainy
  Nooshin Hussainy LinkedIn Profile  Nooshin Hussainy Twitter Account  Nooshin Hussainy News  Nooshin Hussainy on Facebook
VP - Regulatory Affairs
Amy VandenBerg
  Amy VandenBerg LinkedIn Profile  Amy VandenBerg Twitter Account  Amy VandenBerg News  Amy VandenBerg on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/14/2015: Apama Medical venture capital transaction
Next: 1/14/2015: Boxed venture capital transaction

 

Share this article

 

About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.